Predicting drug properties with parameter-free machine learning: Pareto-Optimal Embedded Modeling (POEM)
The prediction of absorption, distribution, metabolism, excretion, and toxicity (ADMET) of small molecules from their molecular structure is a central problem in medicinal chemistry with great practical importance in drug discovery. Creating predictive models conventionally requires substantial trial-and-error for the selection of molecular representations, machine learning (ML) algorithms, and hyperparameter tuning. A generally applicable method that performs well on all datasets without tuning would be of great value but is currently lacking. Here, we describe Pareto-Optimal Embedded Modeling (POEM), a similarity-based method for predicting molecular properties. POEM is a non-parametric, supervised ML algorithm developed to generate reliable predictive models without need for optimization. POEMs predictive strength is obtained by combining multiple different representations of molecular structures in a context-specific manner, while maintaining low dimensionality. We benchmark POEM relative to industry-standard ML algorithms and published results across 17 classifications tasks. POEM performs well in all cases and reduces the risk of overfitting.
Code (0)
등록된 구현이 없습니다.
Tasks
BIG-bench Machine LearningDrug DiscoverySimilar Papers 제목 키워드 기반
AMFPMC -- An improved method of detecting multiple types of drug-drug interactions using only known drug-drug interactions
Adverse drug interactions are largely preventable causes of medical accidents, which frequently result in physician and emergency room encounters. The detection of drug interactions in a lab, prior to a drug's use in med…
Machine Learning Small Molecule Properties in Drug Discovery
Machine learning (ML) is a promising approach for predicting small molecule properties in drug discovery. Here, we provide a comprehensive overview of various ML methods introduced for this purpose in recent years. We re…
Decision MakingDrug DiscoveryPredicting Early and Complete Drug Release from Long-Acting Injectables Using Explainable Machine Learning
Polymer-based long-acting injectables (LAIs) have transformed the treatment of chronic diseases by enabling controlled drug delivery, thus reducing dosing frequency and extending therapeutic duration. Achieving controlle…
PotentialNet for Molecular Property Prediction
The arc of drug discovery entails a multiparameter optimization problem spanning vast length scales. They key parameters range from solubility (angstroms) to protein-ligand binding (nanometers) to in vivo toxicity (meter…
ARCBIG-bench Machine LearningClusteringDrug Discovery+4Towards Evolutionary-based Automated Machine Learning for Small Molecule Pharmacokinetic Prediction
Machine learning (ML) is revolutionising drug discovery by expediting the prediction of small molecule properties essential for developing new drugs. These properties -- including absorption, distribution, metabolism and…
AutoMLDrug Discovery